2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Tuesday, May 2, 2017

5:06pm-5:18pm: Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.

J. Ramirez,¹ H. Aghil,¹ M. Baz,³ B. Sawaya,¹ N. Rajagopalan,² X. Mei,³ R. Gedaly,³ A. El-Husseini.¹

Concurrent Session: Kidney General Outcomes • E354a

5:06pm-5:18pm: The mTOR Signal Regulates Myeloid Derived Suppressor Cells Differentiation and Immunosuppressive Function in Acute Kidney Injury.

C. Yang, C. Zhang, R. Rong, T. Zhu.

Concurrent Session: Pathways in Ischemia Reperfusion • E351

5:18pm-5:30pm: A Combination of Anti-CD40L-Ab, Rapamycin, and Donor Apoptotic Cells Prolongs Allogeneic Pancreatic Islet Survival in Sensitized Mice by Regulating Memory Responses.

A. Dangi,¹ H.-K. Kang,¹ X. Zhang,^2,3 X. Luo.^1,2,3

Concurrent Session: Islet Transplant • E352

5:18pm-5:30pm: Analysis of Outcomes in High Risk Kidney Transplants.

E. Liu, M. Aull, J. Lee, S. Kapur.

Concurrent Session: Economics and Outcomes in Organ Transplantation • E271a

5:18pm-5:30pm: CD8+ TAb-supp Cells Suppress the Production of Multiple Alloantibody Isotypes in Response to MHC-Mismatched Cellular and Vascularized Allografts.

J. Zimmerer, C. Avila, S. Elzein, B. Ringwald, G. Bumgardner.

Concurrent Session: B Cells: Regulation and Tolerance • E350

5:18pm-5:30pm: Center-Level Differences in Outcomes Following High-KDPI Kidney Transplants.

L. Wu, A. Massie, X. Luo, M. Bowring, D. Segev.

Concurrent Session: Long Term Kidney Graft Survival II • E450a

5:18pm-5:30pm: Dialysis Facility Providers' Awareness of Racial Disparities in Kidney Transplantation.

J. Kim, M. Basu, L. Plantinga, C. Escoffery, S. Pastan, R. Patzer.

Concurrent Session: Disparities in Kidney Transplantation • E451a

5:18pm-5:30pm: Donor-Derived Nonclassical Monocytes Produce MIP-2 to Recruit Recipient Neutrophils and Cause Ischemia Reperfusion Injury After Lung Transplant.

S. Chiu,¹ Z. Zheng,¹ M. Akbarpour,¹ R. Fernandez,¹ A. McQuattie-Pimentel,¹ P. Reyfman,¹ K. Anekalla,¹ D. Kreisel,² H. Perlman,¹ G. Budinger,¹ A. Misharin,¹ A. Bharat.¹

Concurrent Session: Pathways in Ischemia Reperfusion • E351

5:18pm-5:30pm: Emerging Safety and Tolerability of Obinutuzumab, a Type 2 Anti-CD20 Monoclonal Antibody for the Desensitization of Renal Transplant Candidates.

R. Redfield,¹ S. Jordan,² T. Schindler,³ H. Tran,⁴ C. Looney,⁴ C. Green,⁴ A. Morimoto,⁴ R. Rajwanshi,⁴ M. Cascino,⁴ P. Brunetta,⁴ D. Borie.⁴

Concurrent Session: Late Breaking • E353C

5:18pm-5:30pm: FOXP3 rs3761548 A/C+A/A Genotype Is a Risk Factor for Steroid Resistant Rejection After Liver Transplantation.

Y. Tanaka, V. Sapana, H. Ohdan.

Concurrent Session: Liver: Immunosuppression and Rejection • E451b